Focus on nocturia in the elderly

Aging Health

Volumn 9, Issue 4, 2013, Pages 389-402

  Osman, Nadir I ^a   Chapple, Christopher R ^a  

^a ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

aging; desmopressin; elderly; lower urinary tract symptoms; nocturia; nocturnal polyuria

Indexed keywords

ALFUZOSIN; ANTICONVULSIVE AGENT; ANTIHYPERTENSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; CORTICOSTEROID; DESMOPRESSIN; DIURETIC AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; DOXAZOSIN; DUTASTERIDE; FINASTERIDE; HYPNOTIC AGENT; LITHIUM; MONOAMINE OXIDASE INHIBITOR; PLACEBO; SEROTONIN UPTAKE INHIBITOR; SOLIFENACIN; TAMSULOSIN; TERAZOSIN; TOLTERODINE;

AGED; AGING; BLADDER CANCER; BLADDER NECK STENOSIS; BODY POSITION; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL EVALUATION; COMPRESSION STOCKING; DAYTIME SOMNOLENCE; DIET RESTRICTION; DISEASE ASSOCIATION; DRUG DOSE COMPARISON; DRUG DOSE TITRATION; DRUG EFFICACY; ELDERLY CARE; EVENING DOSAGE; EXERCISE; FALLING; FLUID RESTRICTION; HUMAN; HYPONATREMIA; INCIDENCE; INSOMNIA; INTERNATIONAL CONSULTATION ON INCONTINENCE NOCTURIA QUALITY OF LIFE QUESTIONNAIRE; INTERNATIONAL PROSTATE SYMPTOM SCORE; LIFESTYLE MODIFICATION; LOWER URINARY TRACT SYMPTOM; MORBIDITY; MORTALITY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NOCTURIA; OVERACTIVE BLADDER; PARKINSON DISEASE; PATHOGENESIS; PELVIC ORGAN PROLAPSE; PHASE 3 CLINICAL TRIAL (TOPIC); POLYURIA; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROSTATITIS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK FACTOR; ROOM TEMPERATURE; SLEEP DISORDER; SLEEP PATTERN; SLEEP QUALITY; TRANSURETHRAL MICROWAVE THERMOTHERAPY; TRANSURETHRAL RESECTION; URETHRA CANCER; URINARY TRACT INFECTION; UROGENITAL ATROPHY; UROGENITAL TRACT DISEASE; UROGENITAL TUBERCULOSIS;

EID: 84881469528     PISSN: 1745509X     EISSN: 17455103     Source Type: Journal    
DOI: 10.2217/ahe.13.22     Document Type: Review

References (117)

1. Ohayon MM. Nocturnal awakenings and comorbid disorders in the American general population. J. Psychiatr. Res. 43(1), 48-54 (2008
2. Middelkoop HA, Smilde-van den Doel DA, Neven AK, Kamphuisen HA, Springer CP. Subjective sleep characteristics of 1,485 males and females aged 50-93: Effects of sex and age, and factors related to self-evaluated quality of sleep. J. Gerontol. Series A. Biol. Sci. Med. Sci. 51(3), M108-M115 (1996
3. Kupelian V, Wei JT, O'Leary MP, Norgaard JP, Rosen RC, Mckinlay JB. Nocturia and quality of life: Results from the Boston area community health survey. Eur. Urol. 61(1), 78-84 (2012
4. Bosch JL, Weiss JP. The prevalence and causes of nocturia. J. Urol. 184(2), 440-446 (2010
5. van Kerrebroeck P, Abrams P, Chaikin D et al. The standardisation of terminology in nocturia: Report from the Standardisation Sub-committee of the International Continence Society. Neurourol. Urodynam. 21(2), 179-183 (2002
6. Weiss JP, Blaivas JG, Bliwise DL et al. The evaluation and treatment of nocturia: A consensus statement. BJU Int. 108(1), 6-21 (2011
7. Coyne KS, Zhou Z, Bhattacharyya SK, Thompson CL, Dhawan R, Versi E. The prevalence of nocturia and its effect on health-related quality of life and sleep in a community sample in the USA. BJU Int. 92(9), 948-954 (2003
8. Johnson TV, Abbasi A, Ehrlich SS, Kleris RS, Raison CL, Master VA. Nocturia associated with depressive symptoms. Urology 77(1), 183-186 (2011
9. Vaughan CP, Brown CJ, Goode PS, Burgio KL, Allman RM, Johnson TM 2nd. The association of nocturia with incident falls in an elderly community-dwelling cohort. Int. J. Clin. Pract. 64(5), 577-583 (2010
10. Nakagawa H, Niu K, Hozawa A et al. Impact of nocturia on bone fracture and mortality in older individuals: A Japanese longitudinal cohort study. J. Urol. 184(4), 1413-1418 (2010
11. Kupelian V, Fitzgerald MP, Kaplan SA, Norgaard JP, Chiu GR, Rosen RC. Association of nocturia and mortality: Results from the Third National Health and Nutrition Examination Survey. J. Urol. 185(2), 571-577 (2011
12. Kupelian V, Rosen RC, Link CL et al. Association of urological symptoms and chronic illness in men and women: Contributions of symptom severity and duration - Results from the BACH Survey. J. Urol. 181(2), 694-700 (2009
13. Kim SC, Lee SY. Men's lower urinary tract symptoms are also mental and physical sufferings for their spouses. J. Korean Med. Sci. 24(2), 320-325 (2009
14. Shvartzman P, Borkan JM, Stoliar L et al. Second-hand prostatism: Effects of prostatic symptoms on spouses' quality of life, daily routines and family relationships. Family Pract. 18(6), 610-613 (2001
15. Macdiarmid S, Rosenberg M. Overactive bladder in women: Symptom impact and treatment expectations. Curr. Med. Res. Opin. 21(9), 1413-1421 (2005
16. Holm-Larsen TWJ, Langkilde LK. Economic burden of nocturia in the US adult population. J. Urol. 183(Suppl.), e1 (2010
17. United Nations. World Population Ageing 1950-2050. United Nations Department of Economic And Social Affairs Population Division, NY, USA (2002
18. Ganong WF. Review of Medical Physiology (22nd). LangeMedical Books/McGraw-Hill, NY, USA (2005
19. Bankir L. Antidiuretic action of vasopressin: Quantitative aspects and interaction between V1a and V2 receptor-mediated effects. Cardiovasc. Res. 51(3), 372-390 (2001
20. Weiss JP, Blaivas JG. Nocturnal polyuria versus overactive bladder in nocturia. Urology 60(5 Suppl. 1), 28-32; discussion 32 (2002
21. Weiss JP, Blaivas JG. Nocturia. J. Urol. 163(1), 5-12 (2000
22. Tikkinen KA, Johnson TM 2nd, Tammela TL et al. Nocturia frequency, bother, and quality of life: How often is too often? A population-based study in Finland. Eur. Urol. 57(3), 488-496 (2010
23. Apostolidis A, Kirana PS, Chiu G, Link C, Tsiouprou M, Hatzichristou D. Gender and age differences in the perception of bother and health care seeking for lower urinary tract symptoms: Results from the hospitalised and outpatients' profile and expectations study. Eur. Urol. 56(6), 937-947 (2009
24. Van Dijk L, Kooij DG, Schellevis FG, Kaptein AA, Boon TA, Wooning M. Nocturia: Impact on quality of life in a Dutch adult population. BJU Int. 93(7), 1001-1004 (2004
25. Roehrborn C, Mcconnell J. Etiology, pathophysiology, epidemiology and natural history of benign prostatic hyperplasia. In: Campbell's Urology. Walsh PRA, Vaughan E, Wein A (Eds). Saunders, PA, USA, 1297-1336 (2002
26. Chute CG, Panser LA, Girman CJ et al. The prevalence of prostatism: A population-based survey of urinary symptoms. J. Urol. 150(1), 85-89 (1993
27. Yoshimura K. Correlates for nocturia: A review of epidemiological studies. Int. J. Urol. 19(4), 317-329 (2012
28. Hernandez C, Estivill E, Prieto M, Badia X. Nocturia in Spanish patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH). Curr. Med. Res. Opin. 24(4), 1033-1038 (2008
29. Epstein RS, Lydick E, Delabry L, Vokonas PS. Age-related differences in risk factors for prostatectomy for benign prostatic hyperplasia: The VA normative aging study. Urology 38(Suppl. 1), S9-S12 (1991
30. Castleden CM, Mcgrother CW, Jagger C, Clark H. A postal survey evaluation of prostatectomy. J. Public Health Med. 16(3), 275-278 (1994
31. Homma Y, Yamaguchi T, Kondo Y, Horie S, Takahashi S, Kitamura T. Significance of nocturia in the International Prostate Symptom Score for benign prostatic hyperplasia. J. Urol. 167(1), 172-176 (2002
32. Wein AJ, Chapple CR. Managing Overactive Bladder. Springer, London, UK (2011
33. Irwin DE, Milsom I, Hunskaar S et al incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: Results of the EPIC study. Eur. Urol. 50(6), 1306-1314; discussion 1314-1305 (2006
34. Schatzl G, Temml C, Schmidbauer J, Dolezal B, Haidinger G, Madersbacher S. Cross-sectional study of nocturia in both sexes: Analysis of a voluntary health screening project. Urology 56(1), 71-75 (2000
35. Weiss JP, Blaivas JG, Jones M, Wang JT, Guan Z. Age related pathogenesis of nocturia in patients with overactive bladder. J. Urol. 178(2), 548-551; discussion 551 (2007
36. Irwin DE, Abrams P, Milsom I, Kopp Z, Reilly K. Understanding the elements of overactive bladder: Questions raised by the EPIC study. BJU Int. 101(11), 1381-1387 (2008
37. Rembratt A, Norgaard JP, Andersson KE. Nocturia and associated morbidity in a community-dwelling elderly population. BJU Int. 92(7), 726-730 (2003
38. Andersson KE, Pehrson R. CNS involvement in overactive bladder: Pathophysiology and opportunities for pharmacological intervention. Drugs 63(23), 2595-2611 (2003
39. Asplund R. Nocturia in relation to sleep, somatic diseases and medical treatment in the elderly. BJU Int. 90(6), 533-536 (2002
40. Lin TL, Ng SC, Chen YC, Hu SW, Chen GD What affects the occurrence of nocturia more: Menopause or age? Maturitas 50(2), 71-77 (2005
41. Rowe JW, Shock NW, Defronzo RA. The influence of age on the renal response to water deprivation in man. Nephron 17(4), 270-278 (1976
42. Sands JM. Urine concentrating and diluting ability during aging. J. Gerontol. Series A. Biol. Sci. Med. Sci. 67(12), 1362-1367 (2012
43. Clerico A, Del Ry S, Maffei S, Prontera C, Emdin M, Giannessi D. The circulating levels of cardiac natriuretic hormones in healthy adults: Effects of age and sex. Clin. Chem. Lab. Med. 40(4), 371-377 (2002
44. Miller M. Nocturnal polyuria in older people: Pathophysiology and clinical implications. J. Am. Geriatr. Soc. 48(10), 1321-1329 (2000
45. Weiss JP, Van Kerrebroeck PE, Klein BM, Norgaard JP. Excessive nocturnal urine production is a major contributing factor to the etiology of nocturia. J. Urol. 186(4), 1358-1363 (2011
46. Van Doorn B, Blanker MH, Kok ET, Westers P, Bosch JL. Prevalence, incidence, and resolution of nocturnal polyuria in a longitudinal community-based study in older men: The Krimpen study. Eur. Urol. 63(3), 542-547 (2013
47. Asplund R, Aberg H. Diurnal variation in the levels of antidiuretic hormone in the elderly. J. Intern. Med. 229(2), 131-134 (1991
48. Ouslander JG, Nasr SZ, Miller M et al. Arginine vasopressin levels in nursing home residents with nighttime urinary incontinence. J. Am. Geriatr. Soc. 46(10), 1274-1279 (1998
49. Hvistendahl GM, Frokiaer J, Nielsen S, Djurhuus JC. Gender differences in nighttime plasma arginine vasopressin and delayed compensatory urine output in the elderly population after desmopressin. J. Urol. 178(6), 2671-2676 (2007
50. Burgio KL, Johnson TM 2nd, Goode PS et al. Prevalence and correlates of nocturia in community-dwelling older adults. J. Am. Geriatr. Soc. 58(5), 861-866 (2010
51. Torimoto K, Hirayama A, Samma S, Yoshida K, Fujimoto K, Hirao Y. The relationship between nocturnal polyuria and the distribution of body fluid: Assessment by bioelectric impedance analysis. J. Urol. 181(1), 219-224; discussion 224 (2009
52. Hirayama A, Torimoto K, Yamada A et al. Relationship between nocturnal urine volume, leg edema, and urinary antidiuretic hormone in older men. Urology 77(6), 1426-1431 (2011
53. Janssens JP, Pautex S, Hilleret H, Michel JP. Sleep disordered breathing in the elderly. Aging (Milano) 12(6), 417-429 (2000
54. Kaynak H, Kaynak D, Oztura I. Does frequency of nocturnal urination reflect the severity of sleep-disordered breathing? J. Sleep Res. 13(2), 173-176 (2004
55. Margel D, Shochat T, Getzler O, Livne PM, Pillar G. Continuous positive airway pressure reduces nocturia in patients with obstructive sleep apnea. Urology 67(5), 974-977 (2006
56. Yalkut D, Lee LY, Grider J, Jorgensen M, Jackson B, Ott C. Mechanism of atrial natriuretic peptide release with increased inspiratory resistance. J. Lab. Clin. Med. 128(3), 322-328 (1996
57. Bliwise DL, Foley DJ, Vitiello MV, Ansari FP, Ancoli-Israel S, Walsh JK. Nocturia and disturbed sleep in the elderly. Sleep Med. 10(5), 540-548 (2009
58. Asplund R, Henriksson S, Johansson S, Isacsson G. Nocturia and depression. BJU Int. 93(9), 1253-1256 (2004
59. Anderson RT, Rajagopalan R. Effects of allergic dermatosis on health-related quality of life. Curr. Allergy Asthma Rep. 1(4), 309-315 (2001
60. Tikkinen KA, Auvinen A, Johnson TM 2nd et al. A systematic evaluation of factors associated with nocturia - The population-based FINNO study. Am. J. Epidemiol. 170(3), 361-368 (2009
61. Asplund R. Nocturia and the burning mouth syndrome (BMS) in the elderly. Arch. Gerontol. Geriatr. 41(3), 255-260 (2005
62. Menefee LA, Cohen MJ, Anderson WR, Doghramji K, Frank ED, Lee H. Sleep disturbance and nonmalignant chronic pain: A comprehensive review of the literature. Pain Med. 1(2), 156-172 (2000
63. Mellinger GD, Balter MB, Uhlenhuth EH. Insomnia and its treatment. Prevalence and correlates. Arch. Gen. Psychiatry 42(3), 225-232 (1985
64. Tjepkema M. Insomnia. Health Reports/Statistics Canada, Canadian Centre for Health Information 17(1), 9-25 (2005
65. Foley DJ, Monjan AA, Brown SL, Simonsick EM, Wallace RB, Blazer DG. Sleep complaints among elderly persons: An epidemiologic study of three communities. Sleep 18(6), 425-432 (1995
66. Webb WB. Sleep in older persons: Sleep structures of 50- to 60-year-old men and women. J. Gerontol. 37(5), 581-586 (1982
67. Foley DJ, Vitiello MV, Bliwise DL, Ancoli-Israel S, Monjan AA, Walsh JK. Frequent napping is associated with excessive daytime sleepiness, depression, pain, and nocturia in older adults: Findings from the National Sleep Foundation '2003 Sleep in America' poll. Am. J. Geriatr. Psychiatry 15(4), 344-350 (2007
68. Ancoli-Israel S. Insomnia in the elderly: A review for the primary care practitioner. Sleep 23(Suppl. 1), S23-S30; discussion S36-S38 (2000
69. Pollak CP, Perlick D, Linsner JP, Wenston J, Hsieh F. Sleep problems in the community elderly as predictors of death and nursing home placement. J. Commun. Health 15(2), 123-135 (1990
70. Sanford Jr. Tolerance of debility in elderly dependants by supporters at home: Its significance for hospital practice. Br. Med. J. 3(5981), 471-473 (1975
71. Asplund R, Aberg H. Health of the elderly with regard to sleep and nocturnal micturition. Scand. J. Prim. Health Care 10(2), 98-104 (1992
72. Chartier-Kastler E, Chapple CR. LUTS/BPH in clinical practice: The importance of nocturia and quality of sleep. BJU Int. 98, 3-8 (2006
73. Vaughan CP, Endeshaw Y, Nagamia Z, Ouslander JG, Johnson TM. A multicomponent behavioural and drug intervention for nocturia in elderly men: Rationale and pilot results. BJU Int. 104(1), 69-74 (2009
74. Vaughan CP, Eisenstein R, Bliwise DL et al. Self-rated sleep characteristics and bother from nocturia. Int. J. Clin. Pract. 66(4), 369-373 (2012
75. Asplund R. Hip fractures, nocturia, and nocturnal polyuria in the elderly. Arch. Gerontol. Geriatr. 43(3), 319-326 (2006
76. Brown JS, Vittinghoff E, Wyman JF et al. Urinary incontinence: Does it increase risk for falls and fractures? Study of osteoporotic fractures research group. J. Am. Geriatr. Soc. 48(7), 721-725 (2000
77. Jensen J, Lundin-Olsson L, Nyberg L, Gustafson Y. Falls among frail older people in residential care. Scand. J. Public Health 30(1), 54-61 (2002
78. Stewart RB, Moore MT, May FE, Marks RG, Hale WE. Nocturia: A risk factor for falls in the elderly. J. Am. Geriatr. Soc. 40(12), 1217-1220 (1992
79. Parsons JK, Mougey J, Lambert L et al. Lower urinary tract symptoms increase the risk of falls in older men. BJU Int. 104(1), 63-68 (2009
80. Temml C, Ponholzer A, Gutjahr G, Berger I, Marszalek M, Madersbacher S. Nocturia is an age-independent risk factor for hip-fractures in men. Neurourol. Urodynam. 28(8), 949-952 (2009
81. van Doorn B, Kok ET, Blanker MH, Westers P, Bosch JL. Mortality in older men with nocturia. A 15-year followup of the krimpen study. J. Urol. 187(5), 1727-1731 (2012
82. Djavan B, Milani S, Davies J, Bolodeoku J. The impact of tamsulosin oral controlled absorption system (OCAS) on nocturia and the quality of sleep: Preliminary results of a pilot study. Eur. Urol. Suppl. 4, 61-68 (2005
83. Kobelt G, Borgstrom F, Mattiasson A. Productivity, vitality and utility in a group of healthy professionally active individuals with nocturia. BJU Int. 91(3), 190-195 (2003
84. Abraham L, Hareendran A, Mills IW et al. Development and validation of a quality-of-life measure for men with nocturia. Urology 63(3), 481-486 (2004
85. Weatherall M, Arnold T. Nocturia in adults: Draft New Zealand guidelines for its assessment and management in primary care. NZ Med. J. 119(1234), U1976 (2006
86. Soda T, Masui K, Okuno H, Terai A, Ogawa O, Yoshimura K. Efficacy of nondrug lifestyle measures for the treatment of nocturia. J. Urol. 184(3), 1000-1004 (2010
87. Sugaya K, Nishijima S, Owan T, Oda M, Miyazato M, Ogawa Y. Effects of walking exercise on nocturia in the elderly. Biomed. Res. 28(2), 101-105 (2007
88. Brubaker L, Fitzgerald MP. Nocturnal polyuria and nocturia relief in patients treated with solifenacin for overactive bladder symptoms. Int. Urogynecol. J. Pelvic Floor Dysfunct. 18(7), 737-741 (2007
89. Vardy MD, Mitcheson HD, Samuels TA et al. Effects of solifenacin on overactive bladder symptoms, symptom bother and other patient-reported outcomes: Results from VIBRANT - A double-blind, placebo-controlled trial. Int. J. Clin. Pract. 63(12), 1702-1714 (2009
90. Cardozo L, Lisec M, Millard R et al. Randomized, double-blind placebo controlled trial of the once daily antimuscarinic agent solifenacin succinate in patients with overactive bladder. J. Urol. 172(5 Pt 1), 1919-1924 (2004
91. Yokoyama O, Yamaguchi O, Kakizaki H et al. Efficacy of solifenacin on nocturia in Japanese patients with overactive bladder: Impact on sleep evaluated by bladder diary. J. Urol. 186(1), 170-174 (2011
92. Rackley R, Weiss JP, Rovner ES, Wang JT, Guan Z. Nighttime dosing with tolterodine reduces overactive bladder-related nocturnal micturitions in patients with overactive bladder and nocturia. Urology 67(4), 731-736; discussion 736 (2006
93. Dubeau CE, Yalla SV, Resnick NM. Implications of the most bothersome prostatism symptom for clinical care and outcomes research. J. Am. Geriatr. Soc. 43(9), 985-992 (1995
94. Johnson TM 2nd, Burrows PK, Kusek JW et al. The effect of doxazosin, finasteride and combination therapy on nocturia in men with benign prostatic hyperplasia. J. Urol. 178, 2045-2050; discussion 2050-2051 (2007
95. Roehrborn CG, Van Kerrebroeck P, Nordling J. Safety and efficacy of alfuzosin 10 mg once-daily in the treatment of lower urinary tract symptoms and clinical benign prostatic hyperplasia: A pooled analysis of three double-blind, placebo-controlled studies. BJU Int. 92(3), 257-261 (2003
96. Johnson TM 2nd, Jones K, Williford WO, Kutner MH, Issa MM, Lepor H. Changes in nocturia from medical treatment of benign prostatic hyperplasia: Secondary analysis of the department of veterans affairs cooperative study trial. J. Urol. 170(1), 145-148 (2003
97. Kaplan SA, Roehrborn CG, Chancellor M, Carlsson M, Bavendam T, Guan Z. Extended-release tolterodine with or without tamsulosin in men with lower urinary tract symptoms and overactive bladder: Effects on urinary symptoms assessed by the International Prostate Symptom Score. BJU Int. 102(9), 1133-1139 (2008
98. Chapple C, Herschorn S, Abrams P, Sun F, Brodsky M, Guan Z. Tolterodine treatment improves storage symptoms suggestive of overactive bladder in men treated with α-blockers. Eur. Urol. 56(3), 534-541 (2009
99. Hakenberg OW, Pinnock CB, Marshall VR. The follow-up of patients with unfavourable early results of transurethral prostatectomy. BJU Int. 84(7), 799-804 (1999
100. Antunes AA, Srougi M, Coelho RF, Leite KR, Freire Gde C. Transurethral resection of the prostate for the treatment of lower urinary tract symptoms related to benign prostatic hyperplasia: How much should be resected? Int. Braz. J. Urol. 35(6), 683-689; discussion 689-691 (2009
101. Van Dijk MM, Wijkstra H, Debruyne FM, De La Rosette JJ, Michel MC. The role of nocturia in the quality of life of men with lower urinary tract symptoms. BJU Int. 105, 1141-1146 (2010
102. Margel D, Lifshitz D, Brown N, Lask D, Livne PM, Tal R. Predictors of nocturia quality of life before and shortly after prostatectomy. Urology 70(3), 493-497 (2007
103. Andersson K, Chapple CR, Cardozo L, Cruz F, Hashim H, Michel M. Pharmacological treatment of urinary incontinence. In: Continence. Health Publications Ltd, Paris, France, 631-699 (2009
104. Lose G, Lalos O, Freeman RM, Van Kerrebroeck P. Efficacy of desmopressin (Minirin) in the treatment of nocturia: A double-blind placebo-controlled study in women. Am. J. Obstet. Gynecol. 189(4), 1106-1113 (2003
105. van Kerrebroeck P, Rezapour M, Cortesse A, Thuroff J, Riis A, Norgaard JP. Desmopressin in the treatment of nocturia: A double-blind, placebo-controlled study. Eur. Urol. 52, 221-229 (2007
106. Mattiasson A, Abrams P, Van Kerrebroeck P, Walter S, Weiss J. Efficacy of desmopressin in the treatment of nocturia: A double-blind placebo-controlled study in men. BJU Int. 89(9), 855-862 (2002
107. Weiss JP, Zinner NR, Daneshgari F. Desmopressin orally disintegrating tablet effectively reduces symptoms of nocturia and prolongs undisturbed sleep in patients with nocturia: Results of a large randomized trial. Neurourol. Urodyn. 29, 805 (2010
108. Lose G, Mattiasson A, Walter S et al. Clinical experiences with desmopressin for long-term treatment of nocturia. J. Urol. 172(3), 1021-1025 (2004
109. Wang CJ, Lin YN, Huang SW, Chang CH. Low dose oral desmopressin for nocturnal polyuria in patients with benign prostatic hyperplasia: A double-blind, placebo controlled, randomized study. J. Urol. 185(1), 219-223 (2011
110. Weiss JP, Zinner NR, Klein BM, Norgaard JP. Desmopressin orally disintegrating tablet effectively reduces nocturia: Results of a randomized, double-blind, placebo-controlled trial. Neurourol. Urodyn. 31(4), 441-447 (2012
111. Liu JSN, Zheng W, Ji H et al. Sex differences in vasopressin V2 receptor. FASEB J. 22(Suppl. 1), S1159-S1124 (2008
112. Juul KV, Klein BM, Sandstrom R, Erichsen L, Norgaard JP. Gender difference in antidiuretic response to desmopressin. Am. J. Physiol. Renal Physiol. 300(5), F1116-F1122 (2011
113. Cornu JN, Abrams P, Chapple CR et al. A contemporary assessment of nocturia: Definition, epidemiology, pathophysiology, and management - A systematic review and meta-analysis. Eur. Urol. 62(5), 877-890 (2012
114. Rembratt A, Riis A, Norgaard JP. Desmopressin treatment in nocturia: An analysis of risk factors for hyponatremia. Neurourol. Urodyn. 25(2), 105-109 (2006
115. NICE. The management of lower urinary tract symptoms in men. NICE, London, UK (2010).
116. Guilleminault C, Lin CM, Goncalves MA, Ramos E. A prospective study of nocturia and the quality of life of elderly patients with obstructive sleep apnea or sleep onset insomnia. J. Psychosom. Res. 56(5), 511-515 (2004
117. Fitzgerald MP, Mulligan M, Parthasarathy S. Nocturic frequency is related to severity of obstructive sleep apnea, improves with continuous positive airways treatment. Am. J. Obstet. Gynecol. 194(5), 1399-1403 (2006